颌面部巨大基底细胞癌的外科治疗:切除与重建策略
回顾性分析2010至2020年5926例颌面部基底细胞癌患者,其中32例巨大基底细胞癌(直径≥5 cm)。总结切除与即刻重建策略,队列5年总生存率87.5%、无病生存率93.75%、疾病特异性生存率96.88%。作者认为单期积极切除与重建并发症率低、肿瘤控制良好且美观可接受。
要点
- 巨大基底细胞癌定义为直径≥5 cm,可深部组织侵犯。
- 32例中位直径8 cm,24例(75%)为原发,8例(25%)为复发。
- 重建以局部皮瓣(15例,46.88%)和局部区域皮瓣(10例,31.25%)为主。
核心结论
- 作者认为单期积极手术切除与重建可获得低并发症率、良好肿瘤控制和可接受的美观效果。
研究设计与样本
- 回顾性分析2010至2020年颌面部基底细胞癌5926例,重点分析其中32例巨大基底细胞癌患者。
- 分析患者与肿瘤特征关联,评估治疗方式并评价临床结局。
主要发现
- 队列男性20例(62.5%)、女性12例(37.5%)(P > 0.05),中位年龄71岁(范围40-86岁)。
- 肿瘤发生至就诊中位时间4年(范围2-7年);24例(75%)为原发,8例(25%)为复发(P < 0.05)。
- 中位肿瘤直径8 cm(范围5-15 cm);局部侵犯软骨31.25%、面部肌肉29.41%、神经组织21.87%、骨18.75%。
- 手术切除包括眶内容物剜除3例(9.38%)、全腮腺切除2例(6.25%)、部分上颌骨切除2例(6.25%)、额部颅面切除2例(6.25%)、部分岩骨切除加乳突切除1例(3.13%)、近全鼻切除1例(3.13%)。
- 重建方式:皮片移植3例(9.38%)、局部皮瓣15例(46.88%)、局部区域皮瓣10例(31.25%)、游离皮瓣4例(12.5%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Giant basal cell carcinoma (GBCC) is a rare and aggressive subtype of basal cell carcinoma (BCC), characterized by a diameter of ≥5 cm and a potential for deep tissue invasion. This study aimed to present our experience with the surgical management of GBCC in the maxillofacial region, focusing on resection and immediate reconstruction strategies. METHODS: We conducted a retrospective analysis of 5926 patients with BCC in the maxillofacial region from 2010 to 2020, with a specific emphasis on 32 patients diagnosed with GBCC. Associations between patient and tumor characteristics were analyzed, treatment approaches evaluated, and clinical outcomes assessed. RESULTS: The cohort comprised 20 males (62.5%) and 12 females (37.5%) ( P > 0.05), with a median age of 71 years (range: 40-86 years). The median time from tumor onset to presentation was 4 years (range: 2-7 years). A total of 24 GBCCs (75%) developed de novo, whereas 8 (25%) were recurrent BCCs ( P < 0.05). The median tumor diameter was 8 cm (range: 5-15 cm), with local invasiveness extending to cartilage in 31.25% of cases, facial muscles in 29.41%, neural tissues in 21.87%, and bone in 18.75%. Surgical resections included orbital exenteration (3 cases, 9.38%), total parotidectomy (2 cases, 6.25%), partial maxillectomy (2 cases, 6.25%), frontal craniofacial resection (2 cases, 6.25%), partial petrosectomy with mastoidectomy (1 case, 3.13%), and near-total rhinectomy (1 case, 3.13%). For reconstruction, a skin graft was used in 3 patients (9.38%), local skin flaps in 15 (46.88%), locoregional flaps in 10 (31.25%), and free flaps in 4 (12.5%). The 5-year overall survival, disease-free survival, and disease-specific survival for the cohort were 87.5%, 93.75%, and 96.88%, respectively. CONCLUSIONS: Our findings suggest that a single-stage procedure featuring aggressive surgical resection and reconstruction achieves low complication rates, excellent oncologic control, and acceptable cosmetic outcomes.
引用
- Pupić-Bakrač J, Pupić-Bakrač A, Matoc L, et al. Surgical Management of Giant Basal Cell Carcinoma in the Maxillofacial Region: Ablative and Reconstructive Strategies. Ann Plast Surg. 2025. PMID: 39843992. doi:10.1097/SAP.0000000000004227
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。